117 related articles for article (PubMed ID: 19250267)
1. Health outcomes of children fathered by patients treated with radioiodine for thyroid cancer.
Garsi JP; Schlumberger M; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henry-Amar M; Bardet S; Rubino C; De Vathaire F
Clin Endocrinol (Oxf); 2009 Dec; 71(6):880-3. PubMed ID: 19250267
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies.
Garsi JP; Schlumberger M; Rubino C; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henri-Amar M; Bardet S; de Vathaire F
J Nucl Med; 2008 May; 49(5):845-52. PubMed ID: 18413399
[TBL] [Abstract][Full Text] [Related]
3. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring.
Bal C; Kumar A; Tripathi M; Chandrashekar N; Phom H; Murali NR; Chandra P; Pant GS
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):449-55. PubMed ID: 16095849
[TBL] [Abstract][Full Text] [Related]
4. Radioiodine therapy for papillary and follicular thyroid carcinoma.
Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine therapy during an unknown remained pregnancy and radiation exposure of the fetus. A case report.
Arndt D; Mehnert WH; Franke WG; Woller P; Laude G; Rockel A; Waller M
Strahlenther Onkol; 1994 Jul; 170(7):408-14. PubMed ID: 8052940
[TBL] [Abstract][Full Text] [Related]
6. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients.
Schlumberger M; De Vathaire F; Ceccarelli C; Delisle MJ; Francese C; Couette JE; Pinchera A; Parmentier C
J Nucl Med; 1996 Apr; 37(4):606-12. PubMed ID: 8691249
[TBL] [Abstract][Full Text] [Related]
7. Effects of I-131 therapy on gonads and pregnancy outcome in patients with thyroid cancer.
Sioka C; Fotopoulos A
Fertil Steril; 2011 Apr; 95(5):1552-9. PubMed ID: 21300333
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment.
Chow SM; Yau S; Lee SH; Leung WM; Law SC
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):992-1000. PubMed ID: 15234032
[TBL] [Abstract][Full Text] [Related]
9. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
Lassmann M; Luster M; Hänscheid H; Reiners C
J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
[No Abstract] [Full Text] [Related]
10. Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma.
Balenović A; Vlasić M; Sonicki Z; Bodor D; Kusić Z
Coll Antropol; 2006 Dec; 30(4):743-8. PubMed ID: 17243543
[TBL] [Abstract][Full Text] [Related]
11. Radioiodine treatment complications to the mother and child in patients with differentiated thyroid carcinoma.
Fard-Esfahani A; Hadifar M; Fallahi B; Beiki D; Eftekhari M; Saghari M; Takavar A
Hell J Nucl Med; 2009; 12(1):37-40. PubMed ID: 19330181
[TBL] [Abstract][Full Text] [Related]
12. Radioiodine and radiotherapy in the management of thyroid cancers.
Simpson WJ
Otolaryngol Clin North Am; 1990 Jun; 23(3):509-21. PubMed ID: 1694984
[TBL] [Abstract][Full Text] [Related]
13. [Genetic risk after high dose radioiodine therapy with regard to gonadal dose].
Ehrenheim C; Hauswirth C; Fitschen J; Martin E; Oetting G; Hundeshagen H
Nuklearmedizin; 1997 Aug; 36(5):157-66. PubMed ID: 9380527
[TBL] [Abstract][Full Text] [Related]
14. Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer.
Sarkar SD; Beierwaltes WH; Gill SP; Cowley BJ
J Nucl Med; 1976 Jun; 17(6):460-4. PubMed ID: 944243
[TBL] [Abstract][Full Text] [Related]
15. [Myelodysplastic syndrome following radioiodine treatment of differentiated carcinoma of the thyroid].
García Pascual L; Simó R; Mesa J; Galofré P
Rev Clin Esp; 1992 Jul; 191(3):169-70. PubMed ID: 1502411
[No Abstract] [Full Text] [Related]
16. [Dosimetric measurements and early complications in patients with differentiated thyroid carcinomas treated with radioactive iodine].
Malesević M; Stefanović L; Adzić O; Mihoci Z; Elez D
Med Pregl; 1992; 45(11-12):427-31. PubMed ID: 1344442
[TBL] [Abstract][Full Text] [Related]
17. Role of radioiodine in management of thyroid cancer: experience with 70 cases.
Afroz S; Ahmed K; Yasmeen S; Ahmed F; Nisa L
Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):68-71. PubMed ID: 1303083
[TBL] [Abstract][Full Text] [Related]
18. [Experience with a high-dose therapy concept in metastatic differentiated thyroid cancer].
Grünwald F; Ruhlmann J; Ammari B; Knopp R; Hotze A; Biersack HJ
Nuklearmedizin; 1988 Dec; 27(6):266-71. PubMed ID: 3217257
[TBL] [Abstract][Full Text] [Related]
19. Dosimetry and thyroid cancer: the individual dosage of radioiodine.
Lassmann M; Reiners C; Luster M
Endocr Relat Cancer; 2010 Sep; 17(3):R161-72. PubMed ID: 20448022
[TBL] [Abstract][Full Text] [Related]
20. Radioiodine therapy in differentiated thyroid cancer: a nuclear medicine perspective.
Clarke SE
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):430-7. PubMed ID: 20537878
[No Abstract] [Full Text] [Related]
[Next] [New Search]
